A Phase 1 Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
86
Participants
Timeline
Start Date
January 31, 2015
Primary Completion Date
November 30, 2015
Study Completion Date
May 31, 2016
Conditions
Healthy
Interventions
DRUG
VBP15
DRUG
Placebo
Trial Locations (1)
66219
PRA Health Sciences, Lenexa
All Listed Sponsors
lead
ReveraGen BioPharma, Inc.
INDUSTRY
NCT02415439 - A Phase 1 Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter